• Title/Summary/Keyword: 2-dimensional scanner

Search Result 183, Processing Time 0.019 seconds

Development of Preliminary Quality Assurance Software for $GafChromic^{(R)}$ EBT2 Film Dosimetry ($GafChromic^{(R)}$ EBT2 Film Dosimetry를 위한 품질 관리용 초기 프로그램 개발)

  • Park, Ji-Yeon;Lee, Jeong-Woo;Choi, Kyoung-Sik;Hong, Semie;Park, Byung-Moon;Bae, Yong-Ki;Jung, Won-Gyun;Suh, Tae-Suk
    • Progress in Medical Physics
    • /
    • v.21 no.1
    • /
    • pp.113-119
    • /
    • 2010
  • Software for GafChromic EBT2 film dosimetry was developed in this study. The software provides film calibration functions based on color channels, which are categorized depending on the colors red, green, blue, and gray. Evaluations of the correction effects for light scattering of a flat-bed scanner and thickness differences of the active layer are available. Dosimetric results from EBT2 films can be compared with those from the treatment planning system ECLIPSE or the two-dimensional ionization chamber array MatriXX. Dose verification using EBT2 films is implemented by carrying out the following procedures: file import, noise filtering, background correction and active layer correction, dose calculation, and evaluation. The relative and absolute background corrections are selectively applied. The calibration results and fitting equation for the sensitometric curve are exported to files. After two different types of dose matrixes are aligned through the interpolation of spatial pixel spacing, interactive translation, and rotation, profiles and isodose curves are compared. In addition, the gamma index and gamma histogram are analyzed according to the determined criteria of distance-to-agreement and dose difference. The performance evaluations were achieved by dose verification in the $60^{\circ}$-enhanced dynamic wedged field and intensity-modulated (IM) beams for prostate cancer. All pass ratios for the two types of tests showed more than 99% in the evaluation, and a gamma histogram with 3 mm and 3% criteria was used. The software was developed for use in routine periodic quality assurance and complex IM beam verification. It can also be used as a dedicated radiochromic film software tool for analyzing dose distribution.

A STUDY FOR OCCLUSAL FEATURES OF FIRST PERMANENT MOLAR AND SECOND PRIMARY MOLAR (제 1대구치와 제 2유구치의 교합면 양상에 관한 연구)

  • Jeon, So-Hee;Kim, Jae-Gon;Yang, Yeon-Mi;Baik, Byeong-Ju
    • Journal of the korean academy of Pediatric Dentistry
    • /
    • v.32 no.1
    • /
    • pp.89-100
    • /
    • 2005
  • The purpose of this study was to analyze the morphometrics of primary second molar and permanent first molar. Samples were consisted of normal occlusion in the primary dentition(50 males and 50 females) and permanent dentition(43 males and 43 females). Their upper and lower plaster casts were used and their measuring points were decided, through 3-dimensional laser scanning(3D Scanner, DS4060, LDI, U.S.A.), fitting standard horizontal plane were made for measuring the intercuspal distance, volume of intercuspal area and section curve. The results were as follows; 1. Average distance from the fit plane to the cusp tips of mandibular primary second molar was smaller than any other tooth. (0.05-0.09 mm in male and 0.04-0.09 mm in female). 2. Intercuspal distances of mandibular primary second molar and permanent first molar were larger in male than in female. Especially, there was statistical significance in primary second molar(p<0.05). 3. Intercuspal distance between distobuccal and distolingual cusp was larger in maxillary primary second molar, except cross intercuspal distances. And distances between distal and distolingual cusp, in mandibular primary second molar, between mesiolingual and mesiobuccal cusp, in maxillary first molar, and between distolingual and mesiolingual cusp, in mandibular first molar were larger than any other intercuspal distance. 4. Volume of intercuspal area of primary second molar and permanent first molar was larger in mandible than in maxilla and that of permanent first molar was 1.40-1.75 times of primary second molar (p<0.05). Also it was larger in male than in female, but there was no statistical significance. 5. In most cases, section curves were wider and deeper in permanent dentition than in primary dentition. Except cross intercuspal distances, in maxilla, section curve between mesiobuccal and mesiolingual cusp was the deepest in both dentition. In mandible, section curve between distobuccal and distal cusp was the deepest in permanent dentition and between distolingual and distal cusp was the deepest in primary dentition.

  • PDF

The 3-Dimensional Analysis of the Efficacy of a Belly-Board Device for the Displacement of Small Bowel During Pelvic Irradiation (골반강 방사선치료 중 소장의 이동을 위한 벨리보드의 효과에 대한 3차원적 분석)

  • Lee, Kyung-Ja
    • Radiation Oncology Journal
    • /
    • v.26 no.4
    • /
    • pp.271-279
    • /
    • 2008
  • Purpose: To evaluate the efficacy of a belly-board device (BBD) in reducing the volume of small bowel during four-field pelvic irradiation. Materials and Methods: Twenty-two cancer patients (14 uterine cervical cancer, 6 rectal cancer, and 2 endometrial cancer) scheduled to receive pelvic irradiation were selected for this study. Two sets of CT images were taken with and without the belly-board device using the Siemens 16 channel CT scanner. All patients were set in the prone position. The CT images were transferred to a treatment planning system for dose calculation and volume measurements. The external surfaces of small bowel and the bladder were contoured on all CT scans and the 4-pelvic fields were added. The dose-volume-histogram of the bladder and small bowel, with and without the BBD, were plotted and analyzed. Results: In all patients, the total small bowel volume included in the irradiated fields was reduced when the BBD was used. The mean volume reduction was 35% (range, $1{\sim}79%$) and was statistically significant (p<0.001). The reduction in small bowel volume receiving $10{\sim}100%$ of the prescribed dose was statistically significant when the BBD was used in all cases. Almost no change in the total bladder volume involved was observed in the field (<8 cc, p=0.762). However, the bladder volume receiving 90% of the prescribed dose was 100% in 15/22 patients (68%) and $90{\sim}99%$ in 7/22 patients (32%) with the BBD. In comparison, the bladder volume receiving 90% of the prescribed dose was 100% in 10/22 patients (45%), $90{\sim}99%$ in 7/22 patients (32%), and $80{\sim}89%$ in 5/22 patients (23%) without the BBD. When the BBD was used, an increase in the bladder volume receiving a high dose range was observed Conclusion: This study shows that the use of a BBD for the treatment of cancer in the pelvic area significantly improves small bowel sparing. However, since the BBD pushed the bladder into the treatment field, the bladder volume receiving the high dose could increase. Therefore it is recommended to be considerate in using the BBD when bladder damage is of concern.